ALLPS VERSUS PVO Randomized Controlled Trial
Stopped early · Phase 2
Conditions studied: Liver Tumors Not Resectable in One Surgical Procedure
In brief
This randomized phase II trial compares how well associating liver partition with portal vein ligation for staged hepatectomy (ALPPS) or portal vein occlusion (PVO) works in treating patients with liver cancer. Both treatments are types of 2-stage hepatectomies for removing liver cancer. ALPPS may be more effective than PVO in patients whose disease would traditionally be considered inoperable. * Trial with surgical intervention
Key facts
- Study ID
- NCT01775267
- Run by
- University of Zurich
- People needed
- 7
- Starts
- 2012-11-01
- Expected to finish
- 2015-11-01
- Last updated by the study team
- 2015-06-09
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Washington University — St Louis, Missouri, United States
- Italian Hospital, Department of Surgery, Division of HPB surgery and Liver Transplatn Unit — Buenos Aires, Argentina
- University Hospital Zurich, Division of Visceral and Transplant Surgery — Zurich, Canton of Zurich, Switzerland
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.